2026 Q2 - tulosraportti
41 päivää sitten
‧38 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 11 544 | - | - | ||
| 3 885 | - | - | ||
| 360 | - | - | ||
| 2 429 | - | - | ||
| 457 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 27.8. | ||
2026 Q1 - tulosraportti 22.5. | ||
2025 Q4 - tulosraportti 19.2. | ||
2025 Q3 - tulosraportti 28.11.2025 | ||
2025 Q2 - tulosraportti 28.8.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
·28.9.TA thoughts in daily view 28/9 10:25 After the 4 kr peak on July 24, the price has bottomed at 1.70 kr on Sep 14 and 16. An inverse H&S has thus been completed through the bottom formation. The MA200 line appears to be flattening out at 1.87 kr. MA20 is just turning upwards at 2 kr and a possible midpoint formation (or start of a small triangle/abc pullback) above the 20-line and MA8, both of which are potential support lines. MA50 is downward-sloping at approx. 2.50 kr. The Ichimoku cloud is strongly red 26 days ahead of the price (usually indicates a possible reversal). The Chikou Span line (26 days lagging) is touching the cloud from below and can be expected to enter the price bars within a week. SMACD has turned up from -10 and is at -3.3. My conclusions: After the buy signal in late July (MA50 crossing up through the MA200 line), a reversal can be confirmed if the bottom does not break below 1.70 kr going forward. Support is now found at 2 kr (MA20) and 1.87 kr (MA200) as well as closely at MA8 (currently at 2.11 kr). Resistance where we are now (cloud line) and at just over 2.50 kr (MA50) as well as at approx. 2.63 kr (another cloud line). A probable small triangle is forming (upper side 2.25 kr) or it will be followed by an abc movement with a bottom between 2.10 kr and 1.75 kr confirming the reversal. We will see how it develops...
·24.7.With an expectation of final approval by the end of 2026, I don't think we should count on revenue in the EU before the latter part of 2027, and one should probably not be surprised if it's not until 2028 that real revenue can be booked. We have seen from Brazil how sluggish the process can be. This means it is still crucial that aXivite delivers strong growth, that we start to see some steady revenue from aXiphen in Brazil, and that aXiphen ruminant also gains some momentum before we see positive cash flow. Q2 has historically been a really strong quarter for aXivite, and if they can grow the numbers from Q2 last year, then it looks good. But there is no guarantee. Having said that, I think there is reason for cautious optimism regarding the long-term case. There are many exciting opportunities, but it requires management to be able to execute on them. I look forward to the next report in August, where we will get the next update. In the meantime, potential triggers will be new customers/orders from Brazil.- ·13.7. · MuokattuSo the minutes are ready: https://www.efsa.europa.eu/sites/default/files/2026-07/feedap260630-0702_m.pdf Phenylcapsaicin as zootechnical additive for chickens for fattening (EFSA-Q-2025- 00428) EFSA was requested to deliver an opinion on the safety and efficacy of phenylcapsaicin as a zootechnical additive for chickens for fattening. MEETING MINUTES – 30 June – 02 July 2026 189th FEEDAP Plenary meeting The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety and efficacy. The Panel unanimously adopted the opinion. So we have the approval! It's not entirely official yet. The decision must be officially published before there is a real permit to sell, as I understand it. That could take a couple of months. But that's a technicality.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
41 päivää sitten
‧38 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·28.9.TA thoughts in daily view 28/9 10:25 After the 4 kr peak on July 24, the price has bottomed at 1.70 kr on Sep 14 and 16. An inverse H&S has thus been completed through the bottom formation. The MA200 line appears to be flattening out at 1.87 kr. MA20 is just turning upwards at 2 kr and a possible midpoint formation (or start of a small triangle/abc pullback) above the 20-line and MA8, both of which are potential support lines. MA50 is downward-sloping at approx. 2.50 kr. The Ichimoku cloud is strongly red 26 days ahead of the price (usually indicates a possible reversal). The Chikou Span line (26 days lagging) is touching the cloud from below and can be expected to enter the price bars within a week. SMACD has turned up from -10 and is at -3.3. My conclusions: After the buy signal in late July (MA50 crossing up through the MA200 line), a reversal can be confirmed if the bottom does not break below 1.70 kr going forward. Support is now found at 2 kr (MA20) and 1.87 kr (MA200) as well as closely at MA8 (currently at 2.11 kr). Resistance where we are now (cloud line) and at just over 2.50 kr (MA50) as well as at approx. 2.63 kr (another cloud line). A probable small triangle is forming (upper side 2.25 kr) or it will be followed by an abc movement with a bottom between 2.10 kr and 1.75 kr confirming the reversal. We will see how it develops...
- ·24.7.With an expectation of final approval by the end of 2026, I don't think we should count on revenue in the EU before the latter part of 2027, and one should probably not be surprised if it's not until 2028 that real revenue can be booked. We have seen from Brazil how sluggish the process can be. This means it is still crucial that aXivite delivers strong growth, that we start to see some steady revenue from aXiphen in Brazil, and that aXiphen ruminant also gains some momentum before we see positive cash flow. Q2 has historically been a really strong quarter for aXivite, and if they can grow the numbers from Q2 last year, then it looks good. But there is no guarantee. Having said that, I think there is reason for cautious optimism regarding the long-term case. There are many exciting opportunities, but it requires management to be able to execute on them. I look forward to the next report in August, where we will get the next update. In the meantime, potential triggers will be new customers/orders from Brazil.
- ·13.7. · MuokattuSo the minutes are ready: https://www.efsa.europa.eu/sites/default/files/2026-07/feedap260630-0702_m.pdf Phenylcapsaicin as zootechnical additive for chickens for fattening (EFSA-Q-2025- 00428) EFSA was requested to deliver an opinion on the safety and efficacy of phenylcapsaicin as a zootechnical additive for chickens for fattening. MEETING MINUTES – 30 June – 02 July 2026 189th FEEDAP Plenary meeting The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety and efficacy. The Panel unanimously adopted the opinion. So we have the approval! It's not entirely official yet. The decision must be officially published before there is a real permit to sell, as I understand it. That could take a couple of months. But that's a technicality.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 11 544 | - | - | ||
| 3 885 | - | - | ||
| 360 | - | - | ||
| 2 429 | - | - | ||
| 457 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 27.8. | ||
2026 Q1 - tulosraportti 22.5. | ||
2025 Q4 - tulosraportti 19.2. | ||
2025 Q3 - tulosraportti 28.11.2025 | ||
2025 Q2 - tulosraportti 28.8.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
41 päivää sitten
‧38 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 27.8. | ||
2026 Q1 - tulosraportti 22.5. | ||
2025 Q4 - tulosraportti 19.2. | ||
2025 Q3 - tulosraportti 28.11.2025 | ||
2025 Q2 - tulosraportti 28.8.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·28.9.TA thoughts in daily view 28/9 10:25 After the 4 kr peak on July 24, the price has bottomed at 1.70 kr on Sep 14 and 16. An inverse H&S has thus been completed through the bottom formation. The MA200 line appears to be flattening out at 1.87 kr. MA20 is just turning upwards at 2 kr and a possible midpoint formation (or start of a small triangle/abc pullback) above the 20-line and MA8, both of which are potential support lines. MA50 is downward-sloping at approx. 2.50 kr. The Ichimoku cloud is strongly red 26 days ahead of the price (usually indicates a possible reversal). The Chikou Span line (26 days lagging) is touching the cloud from below and can be expected to enter the price bars within a week. SMACD has turned up from -10 and is at -3.3. My conclusions: After the buy signal in late July (MA50 crossing up through the MA200 line), a reversal can be confirmed if the bottom does not break below 1.70 kr going forward. Support is now found at 2 kr (MA20) and 1.87 kr (MA200) as well as closely at MA8 (currently at 2.11 kr). Resistance where we are now (cloud line) and at just over 2.50 kr (MA50) as well as at approx. 2.63 kr (another cloud line). A probable small triangle is forming (upper side 2.25 kr) or it will be followed by an abc movement with a bottom between 2.10 kr and 1.75 kr confirming the reversal. We will see how it develops...
- ·24.7.With an expectation of final approval by the end of 2026, I don't think we should count on revenue in the EU before the latter part of 2027, and one should probably not be surprised if it's not until 2028 that real revenue can be booked. We have seen from Brazil how sluggish the process can be. This means it is still crucial that aXivite delivers strong growth, that we start to see some steady revenue from aXiphen in Brazil, and that aXiphen ruminant also gains some momentum before we see positive cash flow. Q2 has historically been a really strong quarter for aXivite, and if they can grow the numbers from Q2 last year, then it looks good. But there is no guarantee. Having said that, I think there is reason for cautious optimism regarding the long-term case. There are many exciting opportunities, but it requires management to be able to execute on them. I look forward to the next report in August, where we will get the next update. In the meantime, potential triggers will be new customers/orders from Brazil.
- ·13.7. · MuokattuSo the minutes are ready: https://www.efsa.europa.eu/sites/default/files/2026-07/feedap260630-0702_m.pdf Phenylcapsaicin as zootechnical additive for chickens for fattening (EFSA-Q-2025- 00428) EFSA was requested to deliver an opinion on the safety and efficacy of phenylcapsaicin as a zootechnical additive for chickens for fattening. MEETING MINUTES – 30 June – 02 July 2026 189th FEEDAP Plenary meeting The Panel discussed the draft scientific opinion, and in particular assessed data regarding product safety and efficacy. The Panel unanimously adopted the opinion. So we have the approval! It's not entirely official yet. The decision must be officially published before there is a real permit to sell, as I understand it. That could take a couple of months. But that's a technicality.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 11 544 | - | - | ||
| 3 885 | - | - | ||
| 360 | - | - | ||
| 2 429 | - | - | ||
| 457 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt